Peter M. Hecht
2022 - Cyclerion Therapeutics
In 2022, Peter M. Hecht earned a total compensation of $590.3K as Chief Executive Officer at Cyclerion Therapeutics, a 445% increase compared to previous year.
Compensation breakdown
| Option Awards | $481,683 |
|---|---|
| Salary | $100,000 |
| Other | $8,574 |
| Total | $590,257 |
Hecht received $481.7K in option awards, accounting for 82% of the total pay in 2022.
Hecht also received $100K in salary and $8.6K in other compensation.
Rankings
In 2022, Peter M. Hecht's compensation ranked 4,101st out of 5,760 executives tracked by ExecPay. In other words, Hecht earned more than 28.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,101 out of 5,760 | 29th |
Division Manufacturing | 2,315 out of 3,136 | 26th |
Major group Chemicals And Allied Products | 1,123 out of 1,422 | 21st |
Industry group Drugs | 1,054 out of 1,323 | 20th |
Industry Pharmaceutical Preparations | 771 out of 969 | 20th |
Source: SEC filing on April 3, 2023.
Hecht's colleagues
We found two more compensation records of executives who worked with Peter M. Hecht at Cyclerion Therapeutics in 2022.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019